{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:19:17Z","timestamp":1763018357712},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00277-021-04571-3","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T16:02:51Z","timestamp":1624118571000},"page":"2071-2078","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants"],"prefix":"10.1007","volume":"100","author":[{"given":"Pallavi","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stalin","family":"Ramprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C P","family":"Raghuram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Dhanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat Kumar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"issue":"8","key":"4571_CR1","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bbmt.2013.03.018","volume":"19","author":"GS Booth","year":"2013","unstructured":"Booth GS, Gehrie EA, Bolan CD, Savani BN (2013) Clinical guide to ABO-incompatible allogeneic stem cell transplantation. Biol Blood Marrow Transplant 19(8):1152\u20131158. https:\/\/doi.org\/10.1016\/j.bbmt.2013.03.018","journal-title":"Biol Blood Marrow Transplant"},{"key":"4571_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.bmt.1703135","volume":"28","author":"S Rowley","year":"2001","unstructured":"Rowley S (2001) Hematopoietic stem cell transplantation between red cell incompatible donor\u2013recipient pairs. Bone Marrow Transplant 28:315\u2013321. https:\/\/doi.org\/10.1038\/sj.bmt.1703135","journal-title":"Bone Marrow Transplant"},{"key":"4571_CR3","first-page":"674","volume-title":"Hematopoietic Cell Transplantation","author":"IJ Sniecinski","year":"1999","unstructured":"Sniecinski IJ, O\u2019Donnell MR (1999) Hemolytic complications of hematopoietic cell transplantation. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic Cell Transplantation. Malden, Blackwell Science, pp 674\u2013684"},{"issue":"2","key":"4571_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1182\/blood.V60.2.420.420","volume":"60","author":"HG Braine","year":"1982","unstructured":"Braine HG, Sensenbrenner LL, Wright SK, Tutschka PJ, Saral R, Santos GW (1982) Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 60(2):420\u2013425","journal-title":"Blood"},{"key":"4571_CR5","first-page":"149","volume":"31","author":"J Schwartz","year":"2016","unstructured":"Schwartz J, Padmanabhan A, Aqui N et al (2016) Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence- based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher 31:149\u2013338","journal-title":"J Clin Apher"},{"issue":"1","key":"4571_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1182\/blood.V75.1.290.290","volume":"75","author":"JP Gmur","year":"1990","unstructured":"Gmur JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D, Metaxas M (1990) Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 75(1):290\u2013295","journal-title":"Blood"},{"issue":"1","key":"4571_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.htct.2018.05.007","volume":"41","author":"JAS J\u00fanior","year":"2019","unstructured":"J\u00fanior JAS, Martinho GH, Macedo AV, Ver\u00e7osa MR, Nobre V, Teixeira GM (2019) Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study. Hematol Transfus Cell Ther 41(1):1\u20136. https:\/\/doi.org\/10.1016\/j.htct.2018.05.007","journal-title":"Hematol Transfus Cell Ther"},{"issue":"2","key":"4571_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","volume":"30","author":"G Stussi","year":"2002","unstructured":"Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gm\u00fcr J, Gratwohl A, Seebach JD (2002) Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 30(2):87\u201393. https:\/\/doi.org\/10.1038\/sj.bmt.1703621","journal-title":"Bone Marrow Transplant"},{"key":"4571_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000441507","volume":"43","author":"N Worel","year":"2016","unstructured":"Worel N (2016) ABO-mismatched allogeneic hematopoietic stem cell transplantation. Transfus Med Hemother 43:3\u201312. https:\/\/doi.org\/10.1159\/000441507","journal-title":"Transfus Med Hemother"},{"issue":"11","key":"4571_CR10","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3324\/haematol.12933","volume":"93","author":"HS Okamoto","year":"2008","unstructured":"Okamoto HS, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K, Japan Marrow Donor Program (2008) Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 93(11):1686\u20131693. https:\/\/doi.org\/10.3324\/haematol.12933","journal-title":"Haematologica"},{"key":"4571_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26883","volume":"65","author":"RS Nickel","year":"2018","unstructured":"Nickel RS, Qayed M, Worthington-White D, Stowell SR, Chiang K-Y (2018) Infusion hemolysis after pediatric major ABO-mismatched bone marrow transplant: comparison of two red blood cell depletion techniques. Pediatr Blood Cancer 65:e26883. https:\/\/doi.org\/10.1002\/pbc.26883","journal-title":"Pediatr Blood Cancer"},{"key":"4571_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/sj.bmt.1704579","volume":"34","author":"R Raimondi","year":"2004","unstructured":"Raimondi R, Soli M, Lamparelli T et al (2004) ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 34:321\u2013329","journal-title":"Bone Marrow Transplant"},{"key":"4571_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/sj.bmt.1702572","volume":"26","author":"S Rowley","year":"2000","unstructured":"Rowley S, Liang P, Ulz L (2000) Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant 26:749\u2013757. https:\/\/doi.org\/10.1038\/sj.bmt.1702572","journal-title":"Bone Marrow Transplant"},{"key":"4571_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/bmt.2011.135","volume":"46","author":"S Rowley","year":"2011","unstructured":"Rowley S, Donato M, Bhattacharyya P (2011) Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant 46:1167\u20131185. https:\/\/doi.org\/10.1038\/bmt.2011.135","journal-title":"Bone Marrow Transplant"},{"key":"4571_CR15","first-page":"150","volume":"12","author":"N Daniele","year":"2014","unstructured":"Daniele N, Scerpa MC, Rossi C, Lanti A, Adorno G, Isacchi G, Zinno F (2014) The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when. Blood Transfus 12:150\u2013158","journal-title":"Blood Transfus"},{"key":"4571_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/152581699320207","volume":"8","author":"Z Kor\u00edstek","year":"1999","unstructured":"Kor\u00edstek Z, Mayer J (1999) Bone marrow processing for transplantation using the COBE spectra cell separator. J Hematother Stem Cell Res 8:443\u2013448","journal-title":"J Hematother Stem Cell Res"},{"key":"4571_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bmt.1705031","volume":"36","author":"S Damodar","year":"2005","unstructured":"Damodar S, George B, Mammen J, Mathews V, Srivastav A, Chandy M (2005) Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants. Bone Marrow Transplant 36:233\u2013235","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"4571_CR18","first-page":"267","volume":"3","author":"IJ Webb","year":"1997","unstructured":"Webb IJ, Soiffer RJ, Andersen JW, Cohen CA, Freeman A, Sugrue M, Ritz J, Anderson KC (1997) In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation. Biol Blood Marrow Transplant 3(5):267\u2013272","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"4571_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/trf.15053","volume":"59","author":"J Quek","year":"2019","unstructured":"Quek J, Lee JJ, Lim FL, Diong C, Goh YT, Gopalakrishnan S, Ho A, Hwang W, Koh M, Loh Y, Linn YC (2019) Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant. Transfusion 59(1):335\u2013339","journal-title":"Transfusion"},{"key":"4571_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1046\/j.1537-2995.1995.35795357883.x","volume":"35","author":"W Nussbaumer","year":"1995","unstructured":"Nussbaumer W, Schwaighofer H, Gratwohl A, Kilga S, Sch\u00f6nitzer D, Nachbaur D, Niederwieser D (1995) Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Transfusion 35:592\u2013595. https:\/\/doi.org\/10.1046\/j.1537-2995.1995.35795357883.x","journal-title":"Transfusion"},{"issue":"10","key":"4571_CR21","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/j.1537-2995.2005.00578.x","volume":"45","author":"S Scholl","year":"2005","unstructured":"Scholl S, Klink A, M\u00fcgge LO, Schilling K, H\u00f6ffken K, Sayer HG (2005) Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch. Transfusion 45(10):1676\u20131683","journal-title":"Transfusion"},{"key":"4571_CR22","unstructured":"Shot Definitions 2019. Version 4, effective release date January 2020. https:\/\/www.shotuk.org\/wp- content\/uploads\/myimages\/SHOT-Definitions-update-10.01.20-FINAL.pdf"},{"issue":"2","key":"4571_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/bjh.12017","volume":"159","author":"H Tinegate","year":"2012","unstructured":"Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, Pinchon D, Sewell C, Wells A (2012) Allard S; BCSH Blood Transfusion Task Force. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol 159(2):143\u2013153. https:\/\/doi.org\/10.1111\/bjh.12017","journal-title":"Br J Haematol"},{"issue":"2","key":"4571_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1537-2995.2011.03465","volume":"52","author":"D O'Donghaile","year":"2012","unstructured":"O'Donghaile D, Kelley W, Klein HG, Flegel WA (2012) Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation. Transfusion 52(2):456\u2013458. https:\/\/doi.org\/10.1111\/j.1537-2995.2011.03465","journal-title":"Transfusion"},{"issue":"3 Pt 2","key":"4571_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1423-0410.2009.01292.x","volume":"98","author":"N Worel","year":"2010","unstructured":"Worel N, Panzer S, Reesink HW, Linkesch W, Dickmeiss E, Fischer-Nielsen A, H\u00f6lig K, Stachel D, Zimmermann R, Holter W, Coluccia P, Brilhante D, Watz E, Sigle JP, Gratwohl A, Buser A, Arslan O, Regan F, Edwards M (2010) Transfusion policy in ABO-incompatible allogeneic stem cell transplantation. Vox Sang 98(3 Pt 2):455\u2013467","journal-title":"Vox Sang"},{"issue":"2","key":"4571_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1537-2995.2011.03295.x","volume":"52","author":"C Curley","year":"2012","unstructured":"Curley C, Pillai E, Mudie K, Western R, Hutchins C, Durrant S, Kennedy GA (2012) Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange. Transfusion 52(2):291\u2013297. https:\/\/doi.org\/10.1111\/j.1537-2995.2011.03295.x","journal-title":"Transfusion"},{"key":"4571_CR27","unstructured":"S(P)EAR alert- private e-mail communication to WMDA members and associated transplant centers- December, 2019."},{"key":"4571_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers MED, Lilleby K, Chauncey TR, Storb R, Blume K, Heimfeld S, Rowley S, Appelbaum FR (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175\u2013181","journal-title":"N Engl J Med"},{"issue":"2","key":"4571_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.13356","volume":"94","author":"G Stussi","year":"2009","unstructured":"Stussi G, Halter J, Bucheli E, Valli PV, Seebach L, Gmur J, Gratwohl A, Schanz U, Passweg JR, Seebach JD (2009) Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins. Haematologica 94(2):239\u2013248. https:\/\/doi.org\/10.3324\/haematol.13356","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04571-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T05:11:41Z","timestamp":1626412301000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,19]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4571"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04571-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,19]]},"assertion":[{"value":"28 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors stated that the study have been approved by the appropriate institutional review board and have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Since this is a retrospective study, hence, no formal informed consent is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Since this study was a retrospective medical record\u2013based study, no formal consent was taken from patient for participation. Confidentiality of the patients is maintained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}